Prot# A4091015: A Phase 3 Randomized, Double-Blind Placebo and Naproxen Controlled Multicenter Study of the Analgesic Efficacy and Safety of Tanezumab in Patients with Osteoarthritis of the Knee

Project: Research project

Project Details

StatusFinished
Effective start/end date7/10/097/10/12

Funding

  • INC Research, LLC (A4091015)
  • Pfizer Inc. (A4091015)